pubmed-article:1481542 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1481542 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:1481542 | lifeskim:mentions | umls-concept:C0042510 | lld:lifeskim |
pubmed-article:1481542 | lifeskim:mentions | umls-concept:C0042514 | lld:lifeskim |
pubmed-article:1481542 | pubmed:issue | 15-16 | lld:pubmed |
pubmed-article:1481542 | pubmed:dateCreated | 1993-2-5 | lld:pubmed |
pubmed-article:1481542 | pubmed:abstractText | In the majority of patients with ventricular tachycardia/fibrillation drug treatment is not effective. The non-pharmacological treatment of this high-risk patients is of increasing importance. In Austria about 900 patients per year need non-pharmacological treatment of malignant ventricular arrhythmias. For this purpose 4 or 5 specialized centers would be necessary. | lld:pubmed |
pubmed-article:1481542 | pubmed:language | ger | lld:pubmed |
pubmed-article:1481542 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1481542 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1481542 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1481542 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1481542 | pubmed:issn | 0043-5341 | lld:pubmed |
pubmed-article:1481542 | pubmed:author | pubmed-author:SteinbachKK | lld:pubmed |
pubmed-article:1481542 | pubmed:author | pubmed-author:FrohnerKK | lld:pubmed |
pubmed-article:1481542 | pubmed:author | pubmed-author:PodczeckAA | lld:pubmed |
pubmed-article:1481542 | pubmed:author | pubmed-author:VeitFF | lld:pubmed |
pubmed-article:1481542 | pubmed:author | pubmed-author:Kaltenbrunner... | lld:pubmed |
pubmed-article:1481542 | pubmed:author | pubmed-author:NürnbergMM | lld:pubmed |
pubmed-article:1481542 | pubmed:author | pubmed-author:HiefCC | lld:pubmed |
pubmed-article:1481542 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1481542 | pubmed:volume | 142 | lld:pubmed |
pubmed-article:1481542 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1481542 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1481542 | pubmed:pagination | 367-70 | lld:pubmed |
pubmed-article:1481542 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:1481542 | pubmed:meshHeading | pubmed-meshheading:1481542-... | lld:pubmed |
pubmed-article:1481542 | pubmed:meshHeading | pubmed-meshheading:1481542-... | lld:pubmed |
pubmed-article:1481542 | pubmed:meshHeading | pubmed-meshheading:1481542-... | lld:pubmed |
pubmed-article:1481542 | pubmed:meshHeading | pubmed-meshheading:1481542-... | lld:pubmed |
pubmed-article:1481542 | pubmed:meshHeading | pubmed-meshheading:1481542-... | lld:pubmed |
pubmed-article:1481542 | pubmed:meshHeading | pubmed-meshheading:1481542-... | lld:pubmed |
pubmed-article:1481542 | pubmed:meshHeading | pubmed-meshheading:1481542-... | lld:pubmed |
pubmed-article:1481542 | pubmed:year | 1992 | lld:pubmed |
pubmed-article:1481542 | pubmed:articleTitle | [Non-drug therapy of ventricular tachycardia/ventricular fibrillation]. | lld:pubmed |
pubmed-article:1481542 | pubmed:affiliation | III. Medizinischen Abteilung, Ludwig-Boltzmann-Institut für Arrhythmieforschung, Wilhelminenspital, Wien. | lld:pubmed |
pubmed-article:1481542 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:1481542 | pubmed:publicationType | English Abstract | lld:pubmed |
pubmed-article:1481542 | pubmed:publicationType | Review | lld:pubmed |
pubmed-article:1481542 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |